Preclinical Evaluation of eFT226, a Novel, Potent and Selective eIF4A Inhibitor with Anti-Tumor Activity in B-Cell Malignancies

Autor: Thompson, Peggy A *, Eam, Boreth *, Young, Nathan P *, Fish, Sarah *, Chen, Joan *, Barrera, Maria *, Howard, Haleigh *, Parra, Ana *, Molter, Jolene *, Staunton, Jocelyn *, Hung, Ivy NJ *, Parker, Greg S *, Chiang, Gary G *, Wegerski, Chris J *, Nevarez, Andres *, Clarine, Jeff *, Sperry, Sam *, Xiang, Alan *, Tran, Chinh *, Nilewski, Christian *, Packard, Garrick K *, Michels, Theodore *, Sprengeler, Paul A *, Ernst, Justin T *, Reich, Siegfried H *, Webster, Kevin R *
Zdroj: In Blood 8 December 2017 130 Supplement 1:1530-1530
Databáze: ScienceDirect